Division of Hematology & Thromboembolism

Research

The Division of Hematology & Thromboembolism has achieved world-wide recognition for its research in thrombosis and hemostasis, platelet physiology and function, blood transfusion therapy, the molecular biology of red cell disorders and trials in malignant hematologic diseases. Members of our Division hold Endowed Chairs and Professorships, as well as Canada Research Chairs. Funding for our research comes from a variety of sources, including CIHR, the Heart and Stroke Foundation, and Canadian Blood Services. On average, division members are responsible for over 100 manuscripts per year; many of which are in leading academic journals like the New England Journal of Medicine, Lancet, Circulation, and Blood. A recent evaluation by the Department of Medicine counted over 5500 discrete peer-reviewed publications by our Hematology & Thromboembolism faculty members.

The Department of Medicine houses two research organizations devoted to hematology-based research.  The Thrombosis and Atherosclerosis Research Institute (TaARI, directed by Dr. Jeffrey Weitz) describes its mission as “to reduce death and disability from thrombotic diseases by conducting research into the pathogenesis, prevention, diagnosis and treatment of thrombosis and vascular disease”. The McMaster Centre for Transfusion Research (directed by Dr. Donnie Arnold) is “dedicated to the advancement of evidence-based diagnostic, clinical, and therapeutic practices in transfusion medicine through research, innovation, and training”.